Provided by Tiger Trade Technology Pte. Ltd.

Krystal Biotech Inc.

246.78
+7.062.94%
Post-market: 247.300.5250+0.21%17:34 EST
Volume:258.54K
Turnover:63.22M
Market Cap:7.16B
PE:37.04
High:246.97
Open:239.16
Low:239.16
Close:239.72
52wk High:246.97
52wk Low:122.80
Shares:29.00M
Float Shares:22.98M
Volume Ratio:0.57
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.66
EPS(LYR):3.12
ROE:19.66%
ROA:8.91%
PB:6.29
PE(LYR):79.14

Loading ...

Krish S. Krishnan, President and CEO, Reports Disposal of Krystal Biotech Inc. Common Shares

Reuters
·
Dec 06

Krystal Biotech (KRYS): Assessing Valuation Following Strong Q3 Results and Global Expansion Moves

Simply Wall St.
·
Nov 20

Krystal Biotech Q3 Net Income USD 79.365 Million

Reuters
·
Nov 20

Insiders Favor These 3 Growth Companies With Strong Ownership

Simply Wall St.
·
Nov 13

Krystal Biotech (KRYS): Assessing Valuation Following Strong Earnings Surge and Investor Optimism

Simply Wall St.
·
Nov 13

Investors Shouldn't Be Too Comfortable With Krystal Biotech's (NASDAQ:KRYS) Earnings

Simply Wall St.
·
Nov 10

Evercore ISI Sticks to Their Buy Rating for Krystal Biotech (KRYS)

TIPRANKS
·
Nov 05

Stock Track | Krystal Biotech (KRYS) Soars 5.28% as Chardan Capital Raises Price Target

Stock Track
·
Nov 04

Chardan Raises Price Target on Krystal Biotech to $220 From $216, Keeps Buy Rating

MT Newswires Live
·
Nov 04

Krystal Biotech Is Maintained at Buy by Chardan Capital

Dow Jones
·
Nov 04

Analysts Are Bullish on Top Healthcare Stocks: Krystal Biotech (KRYS), Xenon (XENE)

TIPRANKS
·
Nov 04

Krystal Biotech price target raised to $217 from $212 at Clear Street

TIPRANKS
·
Nov 04

Krystal Biotech (KRYS) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Nov 04

Stock Track | Krystal Biotech Plummets 5.77% Despite Strong Q3 Earnings, Investors Weigh Future Growth Prospects

Stock Track
·
Nov 03

Krystal Biotech sees FY25 non-GAAP R&D, SG&A expense $145M-$155M

TIPRANKS
·
Nov 03

Earnings Flash (KRYS) Krystal Biotech Posts Q3 EPS $2.66, vs. FactSet Est of $0.95

MT Newswires Live
·
Nov 03

Krystal Biotech Q3 EPS $2.66 Beats $1.03 Estimate, Sales $97.800M Beat $93.186M Estimate

Benzinga
·
Nov 03

BRIEF-Krystal Biotech Q3 Net Income USD 79.365 Million

Reuters
·
Nov 03

Krystal Biotech Inc - FDA Grants Platform Technology Designation to Krystal Biotech

THOMSON REUTERS
·
Nov 03

Krystal Biotech Q3 Operating Expenses USD 56.426 Million

THOMSON REUTERS
·
Nov 03